智能手机监测运动管理方案对腹主动脉瘤腔内修复术后患者康复的影响:一项随机对照试验
该随机对照试验拟从四川大学华西医院血管外科招募176例腹主动脉瘤患者,所有患者接受指南标准医疗照护;试验组通过微信接受医护人员运动监测,对照组无移动健康工具实时监测与反馈。主要结局为术后1个月和3个月的生活质量,次要结局包括运动能力、衰弱状态、肌力、静息心率和肺功能,并评估术后1个月内的不良事件。
要点
- 试验组通过微信由医护人员监测运动,对照组无移动健康工具实时监测与反馈。
- 主要结局为术后1个月和3个月的生活质量,次要结局含运动能力、衰弱、肌力、静息心率和肺功能。
- 术后1个月评估全因死亡、非计划再手术、再入院、内漏、主要不良心脑血管事件、肾功能损害和肺部感染等不良事件。
核心结论
- 该试验旨在评估包含3个月医疗监督下运动干预的智能手机监测运动管理方案是否影响腹主动脉瘤腔内修复术后患者的短期生活质量。
- 研究结果将为腹主动脉瘤腔内修复术后患者早期运动的影响提供见解和证据,指导此类患者运动方案的科学制定。
研究设计与样本
- 随机对照试验,拟从四川大学华西医院血管外科招募176例腹主动脉瘤患者。
- 所有参与者按现行指南接受标准医疗照护;试验组通过智能手机使用微信由医护人员追踪运动,对照组无移动健康工具实时监测或反馈。
- 试验持续3个月,在基线和3个月时进行评估,主要结局在术后1个月和3个月评估。
主要发现
- 原文未报告结果。
关键数值与推荐
- 主要结局为术后1个月和3个月的生活质量评估。
- 次要结局包括术后1个月和3个月的运动能力、衰弱状态、肌力、静息心率和肺功能。
- 术后1个月测量不良事件,包括全因死亡、非计划再手术、再入院、内漏、主要不良心脑血管事件、肾功能损害和肺部感染。
- 同时评估运动相关不良事件,如跌倒、损伤和骨折。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Physical exercise is known to enhance vascular function by regulating PPARs, ERs, and RXR signaling pathways. It improves cardiopulmonary capacity through optimized lipid metabolism, immune regulation, and blood pressure reduction. Additionally, exercise reduces postoperative complications by maintaining energy expenditure and skeletal muscle function, which may ultimately improve patients' quality of life (QoL). However, the safety and efficacy of exercise therapy post-endovascular aortic aneurysm repair (EVAR) remain uncertain. Due to the potential impact of exercise training on abdominal pressure, supervised exercise by medical professionals is crucial for ensuring patient safety. Although exercise offers notable benefits, patient adherence tends to be low. Therefore, leveraging smartphones as pervasive monitoring tools may provide timely feedback on patients' exercise status and influence their behavior. This trial aims to assess whether a smartphone-monitored physical exercise management program, including physical exercise interventions under medical supervision for 3 months, affects the short-term QoL of individuals post-EVAR. METHODS: A total of 176 participants with abdominal aortic aneurysms will be recruited from the Department of Vascular Surgery at West China Hospital of Sichuan University. All participants will receive standard medical care according to current guidelines. The experimental group will be monitored via smartphones using WeChat for exercise tracking by medical staff, while the control group will not have real-time monitoring or feedback from mobile health tools. The trial will last 3 months, with assessments at baseline and 3 months. Primary outcomes include QoL assessments at 1 and 3 months post-surgery. Secondary outcomes include exercise capacity, frailty status, muscle strength, resting heart rate, and lung function at 1 and 3 months post-surgery. Additionally, adverse events in the first month post-surgery will be measured, including all-cause mortality, unplanned reoperations, readmissions, endoleaks, major adverse cardiovascular and cerebrovascular events, renal impairment, and pulmonary infections. Exercise-related adverse events, such as falls, injuries, and fractures, will also be assessed. DISCUSSION: The study utilizes smartphones to monitor physical exercise during and after activities. It provides personalized feedback and implements strategies to enhance motivation through engaging activities. The results of this study will provide crucial insights and evidence on the impact of early exercise in patients post-EVAR, guiding the scientific prescription of exercise programs for these patients. Providing exercise instructors and dynamically tailoring exercises to individual cases is crucial for reinforcing patient adherence to smartphone-based tracking and exercise programs. TRIAL REGISTRATION: chictr.org.cn ChiCTR2400083901. Registered on May 7, 2024.
引用
- Huang J, Ren L, Xu J, et al. Effects of a smartphone-monitored physical exercise management program on the recovery of patients after endovascular repair of abdominal aortic aneurysm: a randomized controlled trial. Trials. 2026. PMID: 41709331. doi:10.1186/s13063-025-08948-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。